Related Experiment Video
Updated: Jun 8, 2025

08:12
Isolation of Leukocytes from Human Breast Milk for Use in an Antibody-dependent Cellular Phagocytosis Assay of HIV Targets
Published on: September 6, 2019
7.1K
Research on Maternal Vaccination for HIV Prevention
Krithika P Karthigeyan1, Christian Binuya1, Kenneth Vuong1
1Department of Pediatrics, Weill Cornell Medicine, 413 East 69th Street, BB-869E, New York City, NY 10021, USA.
Clinics in Perinatology
|November 1, 2024
Summary
Preventing mother-to-child HIV transmission requires more than antiretroviral therapy (ART). This review explores immune-based interventions to complement ART for ending the pediatric HIV epidemic.
Area of Science:
- Immunology
- Infectious Diseases
- Public Health
Background:
- Vertical transmission of human immunodeficiency virus (HIV) persists as a key route for pediatric HIV acquisition.
- Despite increased use of antiretroviral therapy (ART) in pregnant individuals with HIV, infant HIV acquisitions remain stagnant.
- Novel strategies are crucial to eliminate the pediatric HIV epidemic.
Purpose of the Study:
- To review immune-based interventions for preventing vertical HIV transmission.
- To evaluate strategies that can be combined with ART in birthing parents.
- To identify challenges associated with these combined approaches.
Main Methods:
- Literature review of immune-based interventions.
- Analysis of synergistic effects with ART.
- Discussion of potential challenges and implementation hurdles.
Main Results:
- Immune-based interventions show promise in preclinical and early clinical studies.
- Combination strategies may offer enhanced protection against vertical HIV transmission.
- Challenges include safety, efficacy, and logistical considerations for widespread implementation.
Conclusions:
- Immune-based interventions represent a potential complementary strategy to ART for preventing vertical HIV transmission.
- Further research and clinical trials are needed to optimize these interventions.
- Addressing implementation challenges is vital for their successful integration into prevention programs.
More Related Videos
Related Concept Videos
Development of Immunocompetence
289
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
289
Vaccinations
44.1K
Overview
44.1K
Sexually Transmitted Infections
283
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
283
Cancer Vaccines
341
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
341

